Cite
MLA Citation
T Lefebvre et al.. “P507 What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?.” Journal of Crohn's and colitis, vol. 12, n.d., pp. S361–S362. http://access.bl.uk/ark:/81055/vdc_100095503446.0x000010